With a coronavirus vaccine still months off, companies are rushing to test what may be the next best thing: drugs that deliver antibodies to fight the virus right away, without having to train the
Antibodies are proteins the body makes when an infection occurs; they attach to a virus and help it be eliminated. Vaccines work by tricking the body into thinking there’s an infection so it makes antibodies and remembers how to do that if the real bug turns up.
They’re also being tested as treatments, to help the immune system and prevent severe symptoms or death. “Our goal is to get something out as soon as possible” and to have hundreds of thousands of doses ready by fall, said Lilly’s chief scientific officer, Dr. Daniel Skovronsky. Lilly is testing two different, single-antibody drugs — one with the Canadian company AbCellera and another with a Chinese company, Junshi Biosciences. In July, Junshi said no safety concerns emerged in 40 healthy people who tried it and that larger studies were getting underway.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Russia to register world’s first vaccine against COVID-19The Philippines may just be a few months away from heaving a sigh of relief as Russia prepares to officially register what could become the world’s first vaccine against COVID-19 (coronavirus disease 2019).
Read more »
DFA reports 3 more COVID-19 cases among overseas Filipinos; total now at 9,757
Read more »
Philippines initially allots P2.4 billion for COVID-19 vaccines
Read more »
Previous vaccines and masks may hold down COVID-19, some researchers sayAs US leaders work to control the spread of coronavirus, researchers across the country and globe are working to answer the mysteries that remain around infections
Read more »
Epekto ng MECQ sa bilang ng kaso ng COVID-19 'di pa ramdam sa mga ospital
Read more »